Possible telaprevir-induced pancreatitis. A case study;Posible pancreatitis inducida por telaprevir. A propósito de un caso

Farmacia Hospitalaria

Volumn 37, Issue 3, 2013, Pages 269-270

  Selvi Sabater, P ^a   Espuny Miro A ^a   Munoz Bertran E D ^a   Plaza Aniorte, J ^a  

^a HOSPITAL MORALES MESEGUER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TELAPREVIR;

CASE STUDY; DRUG INDUCED DISEASE; HUMAN; LETTER; PANCREATITIS;

ABDOMINAL PAIN; ACUTE DISEASE; ANTIVIRAL AGENTS; CAUSALITY; DRUG THERAPY, COMBINATION; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; OLIGOPEPTIDES; PANCREATITIS; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RIBAVIRIN;

EID: 84882316670     PISSN: 11306343     EISSN: 21718695     Source Type: Journal    
DOI: 10.7399/FH.2013.37.3.549     Document Type: Letter

References (8)

1. Yang AL, Vadhavkar S, Singh G, Omary MB. Epidemiology of alcohol-related liver and pancreatic disease in the United States. Arch Intern Med. 2008 Mar 24;168(6):649-56. (Pubitemid 351468400)
2. Chris E. Forsmark, John Baillie. AGA Institute Technical Review on Acute Pancreatitis. Gastroenterology. 2007;132:2022-44. (Pubitemid 46677956)
3. Boletín De la Tarjeta amarilla. Numero 20. Octubre 2004. Centro regional de farmacovigilancia de Castilla y León.
4. Boletín de Publicación de la Dirección General de Farmacia y Productos Sanitarios Farmacovigilancia de la Comunitat Valenciana. Pancreatitis inducida por fármacos. no72.
5. B.W. Marcel Spanier, Hans A.R.E. Tuynman, René W.M. van der Hulst, Marcel G.W. Dijkgraaf, Marco J. Bruno. Acute Pancreatitis and Concomitant Use of Pancreatitis-Associated Drugs. Am J Gastroenterol. 2011;106:2183-8.
6. Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med. 2011;364(25):2405-16.
7. McHutchison JG, Everson GT, Gordon SC, Jacobson IM, Sulkowski M, Kauffman R et al. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. N Engl J Med. 2009;360 (18):1827-38.
8. Ficha Técnica del fármaco. Disponible en: http://www.ema.europa.eu/docs/es-ES/document-library/EPAR-Product-Information/ human/002313/WC500115529.pdf